National population prevalence of antibodies to SARS-CoV-2 in Scotland during the first and second waves of the COVID-19 pandemic

OBJECTIVES: Studies that measure the prevalence of antibodies to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) (‘seroprevalence’) are essential to understand population exposure to SARS-CoV-2 among symptomatic and asymptomatic individuals. We aimed to measure seroprevalence in the Sco...

Descripción completa

Detalles Bibliográficos
Autores principales: Palmateer, N.E., Dickson, E., Furrie, E., Godber, I., Goldberg, D.J., Gousias, P., Jarvis, L., Mathie, L., Mavin, S., McMenamin, J., McNeilly, T.N., Murcia, P., Murray, J., Reid, G., Robertson, C., Templeton, K., von Wissmann, B., Wallace, L.A., Waugh, C., McAuley, A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Royal Society for Public Health. Published by Elsevier Ltd. 2021
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289625/
https://www.ncbi.nlm.nih.gov/pubmed/34411992
http://dx.doi.org/10.1016/j.puhe.2021.07.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8289625/
https://www.ncbi.nlm.nih.gov/pubmed/34411992
http://dx.doi.org/10.1016/j.puhe.2021.07.006

Ejemplares similares